G. Kayman Kürekçi And P. R. Dinçer, "In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes," 42nd FEBS Congress , vol.284, Yerushalayim, Israel, pp.102-403, 2017
Kayman Kürekçi, G. And Dinçer, P. R. 2017. In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes. 42nd FEBS Congress , (Yerushalayim, Israel), 102-403.
Kayman Kürekçi, G., & Dinçer, P. R., (2017). In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes . 42nd FEBS Congress (pp.102-403). Yerushalayim, Israel
Kayman Kürekçi, GÜLSÜM, And Pervin Rukiye Dinçer. "In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes," 42nd FEBS Congress, Yerushalayim, Israel, 2017
Kayman Kürekçi, GÜLSÜM K. And Dinçer, Pervin R. . "In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes." 42nd FEBS Congress , Yerushalayim, Israel, pp.102-403, 2017
Kayman Kürekçi, G. And Dinçer, P. R. (2017) . "In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes." 42nd FEBS Congress , Yerushalayim, Israel, pp.102-403.
@conferencepaper{conferencepaper, author={GÜLSÜM KAYMAN KÜREKÇİ And author={Pervin Rukiye Dinçer}, title={In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes}, congress name={42nd FEBS Congress}, city={Yerushalayim}, country={Israel}, year={2017}, pages={102-403} }